Gemfibrozil treatment of endogenous hypertriglyceridemia : Effect of insulin-mediated glucose disposal and plasma insulin concentrations

Gemfibrozil or placebo was administered for 3 months to 24 individuals with endogenous hypertriglyceridemia and normal glucose tolerance. Mean ( +/- SEM) fasting plasma triglyceride (TG) concentrations decreased (4.01 +/- 0.55 to 1.34 +/- 0.12 mmol/L; P < 0.001) and high density lipoprotein chole...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical endocrinology and metabolism 1996-07, Vol.81 (7), p.2550-2553
Hauptverfasser:	JENG, C.-Y, SHEU, W. H.-H, FUH, M. M.-T, SHIEH, S.-M, IDA CHEN, Y.-D, REAVEN, G. M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Blood Glucose - metabolism Cholesterol, HDL - blood Cholesterol, LDL - blood Cholesterol, VLDL - blood Circadian Rhythm Fatty Acids, Nonesterified - blood Gemfibrozil - therapeutic use General and cellular metabolism. Vitamins Humans Hypertriglyceridemia - blood Hypertriglyceridemia - complications Hypertriglyceridemia - drug therapy Hypolipidemic Agents - therapeutic use Insulin - blood Insulin Resistance Medical sciences Middle Aged Pharmacology. Drug treatments Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!